Last reviewed · How we verify
NCT07291739
A Clinical Evaluation of a Phakic Intraocular Lens
NA trial testing Implantable Collamer Lens (ICL) in Myopia in 47 participants. Completed in 18 October 2024.
18 October 2024
Quick facts
| Lead sponsor | Staar Surgical Company |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 47 |
| Start date | 22 August 2022 |
| Primary completion | 18 October 2024 |
| Estimated completion | 18 October 2024 |
| Sites | 1 location across Philippines |
Drugs / interventions tested
- Implantable Collamer Lens (ICL)
Conditions studied
- Myopia — all drugs for Myopia →
- Hyperopia — all drugs for Hyperopia →
- Astigmatism — all drugs for Astigmatism →
- Presbyopia — all drugs for Presbyopia →
Sponsor
Staar Surgical Company — full company profile →
Who can join
Adults 40 to 60, any sex, with Myopia or Hyperopia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to evaluate the clinical performance of the STAAR EVO+ Visian™ Implantable Collamer® Lens with Aspheric (EDOF) Optic as refractive elements to correct or reduce myopia or hyperopia with presbyopia with or without astigmatism.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07291739
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Implantable Collamer Lens (ICL)
Trials testing the same drug.
- NCT06058780 — Safety and Efficacy of Implantable Collamer Lens Versus Implantable Phakic Lens IPCL in Myopic Patients; A Comparative S · NA · completed
Other recruiting trials for Myopia
Currently open trials in the same condition.
- NCT07284966 — Comfort and Vision With TOTAL30 Multifocal Lenses · recruiting
- NCT07078799 — Wavefront-guided LASIK Surgery Compared to Ray Tracing-Guided LASIK Surgery · NA · recruiting
- NCT07585877 — Effect of Branched-Chain Amino Acid Supplementation on Myopia Progression · NA · active not recruiting
- NCT07354945 — An Evaluation of Myopia Control Lenses on Wearing Experience in Myopic Children · NA · recruiting
- NCT07229365 — Children's Viewing Behavior · NA · recruiting
Other Staar Surgical Company trials
Trials by the same sponsor.
- NCT05538754 — Post-Market Evaluation of the EVO ICL · NA · completed
- NCT04516772 — STAAR Visian Toric ICL Post-Approval Study · NA · completed
- NCT04283149 — Multicenter Clinical Trial of a Phakic Implantable Collamer® Lens (ICL) · NA · completed
- NCT03499821 — Clinical Performance of a Phakic Intraocular Lens (IOL) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07291739 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Staar Surgical Company
- Last refreshed: 18 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07291739.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing